Tong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine

Reuters

09/26

<a href="https://laohu8.com/S/TGRNF">Tong Ren Tang Technologies</a> Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine

**Tong Ren Tang Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, "Tong Ren Tang Angong Niuhuang Wan," to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2570006359"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570006359\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570006359?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-26 17:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570006359","market":"us","top_or_hot":-1,"title":"Tong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/TGRNF\">Tong Ren Tang Technologies</a> Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        **<a href=\"https://laohu8.com/S/01666\">Tong Ren Tang</a> Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, <a href=\"https://laohu8.com/S/600085\">Beijing Tong Ren Tang</a> Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, \"Tong Ren Tang Angong Niuhuang Wan,\" to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-26 17:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/TGRNF\">Tong Ren Tang Technologies</a> Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        **<a href=\"https://laohu8.com/S/01666\">Tong Ren Tang</a> Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, <a href=\"https://laohu8.com/S/600085\">Beijing Tong Ren Tang</a> Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, \"Tong Ren Tang Angong Niuhuang Wan,\" to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL337J1g:1","article_id":"2570006359","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570006359","pubTimestamp":1758878337,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"**Tong Ren Tang Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, \"Tong Ren Tang Angong Niuhuang Wan,\" to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600085":"同仁堂","BK1583":"高瓴概念","BK1515":"抗疫概念","BK0196":"行业龙头","BK1191":"制药","BK0188":"融资融券","03613":"同仁堂国药","LU1688375341.USD":"贝莱德中国灵活股票基金","BK0097":"医药电商","01666":"同仁堂科技","BK0028":"国家队","BK0239":"医药制造","BK0086":"举牌","BK0113":"养老产业","BK0183":"MSCI概念","BK1606":"中医药概念","BK0012":"证金概念"},"translate_title":"同仁堂科技安宫牛黄丸传统药物获柬埔寨监管批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600085":0.9,"01666":0.9,"03613":0.9},"content_text":"Tong Ren Tang Technologies Receives Cambodian Regulatory Approval for Angong Niuhuang Wan Traditional Medicine\n    \n\n        **Tong Ren Tang Technologies Co. Ltd. Receives Regulatory Approval for Traditional Medicine in Cambodia** Tong Ren Tang Technologies Co. Ltd. announced that its subsidiary, Beijing Tong Ren Tang Chinese Medicine Company Limited, has received a traditional medicine registration license from the Department of Drugs and Food of the Ministry of Health of Cambodia. The license allows the company's product, \"Tong Ren Tang Angong Niuhuang Wan,\" to be sold in the Cambodian market. This regulatory approval is expected to help the company expand its distribution channels and market presence in Cambodia. The company noted that the approval will not have a material impact on its current operations or performance, and sales may be affected by local policy changes, exchange rates, and market competition. No other organizations were mentioned as recipients of this regulatory approval.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tong Ren Tang Technologies Co. Ltd. published the original content used to generate this news brief on September 26, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}